LIPOSCIENCE INC (LPDX) [Rocket]

In millions, except per share items	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08
	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues	52.4	54.8	45.8	39.4	34.7	29.0
Revenue growth	-4.4%	19.6%	16.4%	13.4%	19.9%
Cost of goods sold	10.7	10.1	8.5	8.1	7.8	7.4
Gross profit	41.6	44.7	37.3	31.2	26.9	21.6
Gross margin	79.5%	81.6%	81.4%	79.3%	77.6%	74.6%
Selling, general and administrative [+]	39.6	32.8	29.9	22.6	20.0	18.1
Sales and marketing	27.7	22.4	21.3	15.2	13.0	12.1
General and administrative	11.9	10.4	8.6	7.3	7.0	6.0
Research and development				7.3	6.2	7.2
Other operating expenses	12.7	10.0	7.8	-2.7
EBITDA [+]	-9.1	3.2	0.1			1,091.6
EBITDA growth	-380.7%	2522.8%	-97.0%	439.9%	-99.9%
EBITDA margin	-17.3%	5.9%	0.3%	10.4%	2.2%	3770.3%
Depreciation	1.6	1.3	0.5			1,095.4
EBITA	-10.7	2.0	-0.4	4.1	0.8	-3.7
EBITA margin	-20.3%	3.6%	-0.8%	10.4%	2.2%	-12.9%
Amortization of intangibles	0.0	0.0	0.0
EBIT [+]	-10.7	1.9	-0.4	4.1	0.8	-3.7
EBIT growth	-648.8%	-605.5%	-109.4%	439.9%	-120.2%
EBIT margin	-20.4%	3.6%	-0.8%	10.4%	2.2%	-12.9%
Interest expense, net [+]	-0.1	0.0	0.0			-0.2
Interest expense	1.9	0.5	0.4			0.0
Interest income	0.1	0.0	0.0			0.2
Other income (expense), net	12.5	-1.4	0.7	0.2	-0.5	-0.1
Pre-tax income	0.0	0.0	0.0	4.3	0.3	-3.6
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate					0.8%	0.0%
Net income	-12.5	0.2	-1.2	4.3	0.3	-3.6
Net margin	-23.9%	0.4%	-2.5%	11.0%	0.7%	-12.6%

Basic EPS [+]	($0.85)	$0.14	($0.69)	$920.00
Growth	-689.8%	-120.7%	-100.1%
Diluted EPS [+]	($0.85)	$0.09	($0.69)	$617.00
Growth	-1067.7%	-112.6%	-100.1%

Shares outstanding (basic) [+]	14.8	1.7	1.7	0.0
Growth	763.9%	2.5%	35616.5%
Shares outstanding (diluted) [+]	14.8	2.8	1.7	0.0
Growth	426.6%	68.1%	23853.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.